|
Volumn 31, Issue 5, 2007, Pages 402-405
|
Long-term management of an implantable left ventricular assist device using low molecular weight heparin and antiplatelet therapy: A possible alternative to oral anticoagulants
|
Author keywords
Anticoagulation; Bridge to transplantation; Left ventricular assist device; Low molecular weight heparin
|
Indexed keywords
FIBER OPTIC SENSORS;
GOLD NANOPARTICLES;
LEFT VENTRICULAR ASSIST DEVICES;
MOLECULAR WEIGHT;
POLYSACCHARIDES;
ANTI-COAGULATION;
ANTIPLATELETS THERAPY;
BODY WEIGHT;
BRIDGE-TO-TRANSPLANTATION;
CLOPIDOGREL;
DIPYRIDAMOLE;
HEART FAILURE;
LONG-TERM MANAGEMENT;
LOW-MOLECULAR WEIGHT HEPARINS;
THERAPEUTIC DOSE;
PATIENT TREATMENT;
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
BLOOD CLOTTING FACTOR 10A INHIBITOR;
CLOPIDOGREL;
DIPYRIDAMOLE;
ENOXAPARIN;
HEPARIN;
LOW MOLECULAR WEIGHT HEPARIN;
ADOLESCENT;
ADULT;
AGED;
ANTICOAGULATION;
ASSISTED CIRCULATION;
BLEEDING;
CAUSE OF DEATH;
CLINICAL ARTICLE;
CONFERENCE PAPER;
CONTROLLED STUDY;
DEVICE;
DIPLOPIA;
DYSARTHRIA;
FEMALE;
HEART FAILURE;
HEART RIGHT VENTRICLE FAILURE;
HUMAN;
IMPLANTATION;
INTESTINAL BLEEDING;
MALE;
PARESTHESIA;
PRIORITY JOURNAL;
SEPSIS;
STROKE;
THROMBOEMBOLISM;
|
EID: 34247599016
PISSN: 0160564X
EISSN: 15251594
Source Type: Journal
DOI: 10.1111/j.1525-1594.2007.00399.x Document Type: Conference Paper |
Times cited : (26)
|
References (6)
|